Total Funding
61
60
Total FundingGrant raised
Growth Score
-11 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
95231
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
- Nicholas Nicolaides: President, Chief Executive Officer and Co-Founder
- Luigi Grasso: Sr Vice President, Chief Scientific Officer and Co-Founder
About the Company
Navrogen Inc. is a biopharmaceutical company that focuses on the targeted treatment of cancer. The company works on enhancing the immune system to fight cancer by removing the effect of factors produced or induced by tumor cells which inhibit the cancer-fighting humoral immune system.
